Safety of Oral Anticoagulation Therapy Withdrawal after Successful Pulmonary Vein Antrum Isolation in Patients with Atrial Fibrillation and Associated High Risk Factors for Embolic Events (OAT Pilot Study)

Brief Description Of Study

The purpose of the study is to assess the safety of stopping oral anticoagulation therapy (OAT) in patients who have undergone a successful ablation procedure for atrial fibrillation. A successful ablation procedure for atrial fibrillation is defined by the protocol as being arrhythmia free 3 months after the procedure. The study will enroll patients into one of two arms and look at safety in both arms. One arm will have their anticoagulation therapy stopped; the other will remain on it.

Clinical Study Identifier: 815993

Contact research investigator to learn more about this study by filling out the form below.


To: Research Study Investigator
Subject: I am interested in participating in your Research Study
Dear Investigator,
I'm interested in learning more about and participating in your research study named: Safety of Oral Anticoagulation Therapy Withdrawal after Successful Pulmonary Vein Antrum Isolation in Patients with Atrial Fibrillation and Associated High Risk Factors for Embolic Events (OAT Pilot Study)
I am hoping to hear back from you and discuss details of the study

By clicking "Contact Research Team", your contact information will be sent directly to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.